Martha Nason
Martha Nason
Biostatistician, NIAID, NIH
Verifierad e-postadress på
Citeras av
Citeras av
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
MR Betts, MC Nason, SM West, SC De Rosa, SA Migueles, J Abraham, ...
Blood 107 (12), 4781-4789, 2006
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1
X Wu, ZY Yang, Y Li, CM Hogerkorp, WR Schief, MS Seaman, T Zhou, ...
Science 329 (5993), 856-861, 2010
Plasma levels of soluble CD14 independently predict mortality in HIV infection
NG Sandler, H Wand, A Roque, M Law, MC Nason, DE Nixon, ...
Journal of Infectious Diseases 203 (6), 780-790, 2011
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine
RA Seder, LJ Chang, ME Enama, KL Zephir, UN Sarwar, IJ Gordon, ...
Science 341 (6152), 1359-1365, 2013
SPICE: exploration and analysis of post‐cytometric complex multivariate datasets
M Roederer, JL Nozzi, MC Nason
Cytometry Part A 79 (2), 167-174, 2011
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies
NA Doria-Rose, RM Klein, MM Manion, S O'Dell, A Phogat, B Chakrabarti, ...
Journal of virology 83 (1), 188-199, 2009
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
NG Sandler, SE Bosinger, JD Estes, RTR Zhu, GK Tharp, E Boritz, ...
Nature 511 (7511), 601-605, 2014
Perforin expression directly ex vivo by HIV-specific CD8+ T-cells is a correlate of HIV elite control
AR Hersperger, F Pereyra, M Nason, K Demers, P Sheth, LY Shin, ...
PLoS Pathog 6 (5), e1000917, 2010
Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables
NA Doria-Rose, RM Klein, MG Daniels, S O'Dell, M Nason, A Lapedes, ...
Journal of virology 84 (3), 1631-1636, 2010
Rapid development of a DNA vaccine for Zika virus
KA Dowd, SY Ko, KM Morabito, ES Yang, RS Pelc, CR DeMaso, ...
Science 354 (6309), 237-240, 2016
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
M Shingai, OK Donau, RJ Plishka, A Buckler-White, JR Mascola, ...
Journal of Experimental Medicine 211 (10), 2061-2074, 2014
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
R Gautam, Y Nishimura, A Pegu, MC Nason, F Klein, A Gazumyan, ...
Nature 533 (7601), 105-109, 2016
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo
RS Rudicell, Y Do Kwon, SY Ko, A Pegu, MK Louder, IS Georgiev, X Wu, ...
Journal of virology 88 (21), 12669-12682, 2014
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection
SY Ko, A Pegu, RS Rudicell, Z Yang, MG Joyce, X Chen, K Wang, S Bao, ...
Nature 514 (7524), 642-645, 2014
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
AS Ishizuka, KE Lyke, A DeZure, AA Berry, TL Richie, FH Mendoza, ...
Nature medicine 22 (6), 614-623, 2016
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization
IS Georgiev, NA Doria-Rose, T Zhou, Y Do Kwon, RP Staupe, S Moquin, ...
Science 340 (6133), 751-756, 2013
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection
T Yamamoto, DA Price, JP Casazza, G Ferrari, M Nason, ...
Blood, The Journal of the American Society of Hematology 117 (18), 4805-4815, 2011
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial
JE Martin, TC Pierson, S Hubka, S Rucker, IJ Gordon, ME Enama, ...
Journal of Infectious Diseases 196 (12), 1732-1740, 2007
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
JO Ngwuta, M Chen, K Modjarrad, MG Joyce, M Kanekiyo, A Kumar, ...
Science translational medicine 7 (309), 309ra162-309ra162, 2015
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor
A Pegu, Z Yang, JC Boyington, L Wu, SY Ko, SD Schmidt, K McKee, ...
Science translational medicine 6 (243), 243ra88-243ra88, 2014
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20